Loading news...
Trupanion is upgraded to Buy after achieving its first GAAP profit and demonstrating improved financial resilience. Gross margins rose from 12% to 16% (2023–2025), with operating leverage and scalable digital operations supporting sustainable free cash flow growth. TRUP targets 14% subscription revenue growth in 2026, with U.S. pet insurance penetration under 4% and significant runway for expansion.
WASHINGTON, March 10, 2026 /PRNewswire/ -- The Human Animal Bond Research Institute (HABRI) today announced a new partnership with Trupanion, a leading provider of pet insurance, to advance shared efforts that support and strengthen the human–animal bond. This partnership brings together HABRI's leadership in human–animal bond research with Trupanion's innovative approach to pet insurance, including its work to support veterans and service dogs.
Executives from Trupanion (NASDAQ: TRUP) outlined their outlook for 2026, discussed evolving customer acquisition strategy, and addressed capital allocation priorities during a conference fireside chat featuring President and CEO Margi Tooth and Chief Financial Officer Fawwad Qureshi. 2026 outlook: pricing still leads, with growing role for headcount Qureshi said the company was "super happy" with its
Accident and Health Insurance stocks like GL, TRUP and EIG are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.
SEATTLE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today that members of Trupanion's management team will participate in two upcoming investor conferences: The BofA Securities 2026 Animal Health Summit, taking place virtually on Thursday, February 26, 2026. Margi Tooth, Chief Executive Officer and President, and Fawwad Qureshi, Chief Financial Officer, are scheduled to present at 12:25 p.m.
Shares of Trupanion, Inc. (NASDAQ: TRUP - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, two have assigned a buy recommendation and one has assigned
Trupanion, Inc. (TRUP) Q4 2025 Earnings Call Transcript
While the top- and bottom-line numbers for Trupanion (TRUP) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Trupanion (TRUP) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.04 per share a year ago.
SEATTLE, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2025. “Since 2021, we've delivered more than $500 million in discretionary profit, growing at a 22% CAGR, including over $150 million last year alone,” said Margi Tooth, Chief Executive Officer and President of Trupanion.
Industry-Leading Retention and 24/7/365 Contact Center Support Drive Global Recognition for Pet Medical Insurance Leader Industry-Leading Retention and 24/7/365 Contact Center Support Drive Global Recognition for Pet Medical Insurance Leader
Trupanion (TRUP) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Trupanion (TRUP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
From Canada to the U.S. and now Continental Europe, Trupanion has helped more than 3.8 million pet parents budget for the unexpected. SEATTLE, Jan. 27, 2026 /PRNewswire/ -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of pet medical insurance in North America, is celebrating its 25th anniversary - a milestone that reflects a legacy of transforming how pet parents around the world approach care for their four-legged family members.
SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 fourth quarter and full year after the market closes on Thursday, February 12, 2026. The company will host a conference call that day beginning shortly after 1:30 p.m.
Trupanion, Inc. (NASDAQ: TRUP - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six analysts that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, two have given a buy recommendation and one has
SEATTLE, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Trupanion, a leading provider of pet medical insurance, announced today they have been named one of Seattle's Best Places to Work for the seventh year in a row.
Trupanion, Inc. (NASDAQ: TRUP - Get Free Report) has received a consensus rating of "Hold" from the five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating on the company. The average
Pet spending stayed resilient in 2025 despite inflation. See which pet care stocks Wall Street is watching heading into 2026.
Chewy Inc. gained 12% during the quarter as the company delivered solid results driven by higher autoship subscription activity and expanding private-label offerings. The largest contributors to Fund performance during the quarter included Chewy Inc. (CHWY) (9.5% of net assets as of September 30, 2025; 12%), Zoetis Inc. (ZTS) (8.1%; 8%), and Freshpet Inc. (FRPT) (4.8%; 10%). The largest detractors were Trupanion Inc. (TRUP) (5.4%; -6%), Petco Health & Wellness (WOOF) (4.3%; -10%), and CVS Group plc (CVS) (7.0%; -5%).